Hypertension Diagnostics, Inc.
OTC: HDII0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Financial Services
- Industry
- Shell Companies
- CEO
- Liangjian Peng
- Employees
- 3
- Headquarters
- Richmond Hill, Canada
- IPO year
- 1998
- Market cap
- $13.7K
- Website
- https://www.hypertensiondiagnostics.com
Loading HDII…
Loading profile data…Frequently asked questions about HDII
What does Hypertension Diagnostics, Inc. (HDII) do?
Hypertension Diagnostics, Inc. (HDII) is a company that designs, develops, manufactures, and commercializes its own innovative, non-invasive medical technologies. These devices are engineered to identify minute changes in the flexibility of arteries, serving both domestic and international markets. Central to their offerings is the CVProfilor, a...
Where does HDII trade?
Hypertension Diagnostics, Inc. (HDII) trades on the Other OTC.
What sector is HDII in?
Hypertension Diagnostics, Inc. (HDII) operates in the Financial Services sector, specifically in the Shell Companies industry.
Who is the CEO of Hypertension Diagnostics, Inc.?
Liangjian Peng is the chief executive officer of Hypertension Diagnostics, Inc. (HDII).
Where is Hypertension Diagnostics, Inc. headquartered?
Hypertension Diagnostics, Inc. is headquartered in Canada.
Does HDII pay a dividend?
Hypertension Diagnostics, Inc. (HDII) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did HDII go public?
Hypertension Diagnostics, Inc. (HDII) completed its initial public offering in 1998.